Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador kfgo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kfgo.com Daily Mail and Mail on Sunday newspapers.
Updated December 18, 2020 8:39am Two more American biopharmaceutical firms Moderna and Arcturus are ready to supply four to 25 million of their respective COVID-19 vaccines to the Philippines, Manila s top diplomat to Washington said Friday. Philippine Ambassador Jose Manuel Romualdez said the vaccines will be ready beginning third quarter of 2021 should the Philippine government find their proposals acceptable. We are hoping our government will consider the promising candidates of Moderna and Arcturus for inclusion in our country s pool of anti-COVID vaccines, Romualdez said in a statement. A US panel of experts has voted to recommend emergency approval of Moderna s COVID-19 vaccine, paving the way for six million doses to start shipping as soon as this weekend.
Galvez: No bus missed, no ball dropped in COVID-19 vaccine talks inquirer.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.net Daily Mail and Mail on Sunday newspapers.
The Straits Times
The US Food and Drug Administration is expected to grant Moderna emergency use authorisation soon.PHOTO: AFP
PublishedDec 18, 2020, 11:47 am SGT
https://str.sg/JaHH
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
Get unlimited access to all stories at $0.99/month for the first 3 months.
including the ST News Tablet worth $398.
Duque: Pfizer was keen to prioritize PH, but no details set inquirer.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.net Daily Mail and Mail on Sunday newspapers.